Ayako Makuuchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayako Makuuchi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hiroki Namikawa
Department of Medical Education and General Practice, Osaka Metropolitan University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan
1 shared publication - Hiromu Tanaka
Department of Palliative Care, Higashi Sumiyoshi Morimoto Hospital, Osaka, Japan
1 shared publication - Masanori Kobayashi
Department of Medical Education and General Practice, Osaka City University, Graduate School of Medicine, Osaka, Japan
1 shared publication - Mina Morimura
Department of Medical Education and General Practice, Osaka City University Graduate School and Faculty of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585 Japan
1 shared publication - Shigeki Kinuhata
Department of Medical Education and General Practice, Osaka City University Graduate School and Faculty of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585 Japan
1 shared publication - Taichi Shuto
Second Department of Surgery, Osaka City University Medical School, Japan
1 shared publication
Latest Publications
- Open Access
- 13 October 2016
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-6
Disseminated carcinomatosis of the bone marrow from pancreatic cancer: a case report
Most cases of disseminated carcinomatosis of the bone marrow (DCBM) arise from gastric cancer. DCBM from pancreatic cancer is very rare. We herein present a case of DCBM from pancreatic cancer. A 57-year-old man was referred to our hospital for severe lumbago. Laboratory data indicated that he suffered from disseminated intravascular coagulation (DIC). Non-contrast abdominal computed tomography (CT) revealed multiple bone masses but no other abnormal findings. Left iliac bone marrow biopsy revealed poorly differentiated adenocarcinoma cells. Positron emission tomography (PET)-CT showed diffuse abnormal uptake in the bones and tail of the pancreas. Contrast whole-body CT showed a tumor measuring approximately 28 mm in diameter with poor enhancement in the tail of the pancreas. The patient’s final diagnosis was pancreatic cancer located in the tail of the pancreas with diffuse bone metastases and DIC. His DCBM was thus believed to originate from the pancreatic cancer. He succumbed to the disease approximately 2 months after admission to our hospital. We herein describe a case of pancreatic cancer located in the tail of the pancreas with diffuse bone metastases and DIC, which, in our case, was DCBM. Therefore, in cases of DCBM with an unknown primary tumor, pancreatic cancer should be considered during differential diagnosis.
- 13 October 2016
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-6
Open AccessDisseminated carcinomatosis of the bone marrow from pancreatic cancer: a case report
Most cases of disseminated carcinomatosis of the bone marrow (DCBM) arise from gastric cancer. DCBM from pancreatic cancer is very rare. We herein present a case of DCBM from pancreatic cancer. A 57-year-old man was referred to our hospital for severe lumbago. Laboratory data indicated that he suffered from disseminated intravascular coagulation (DIC). Non-contrast abdominal computed tomography (CT) revealed multiple bone masses but no other abnormal findings. Left iliac bone marrow biopsy revealed poorly differentiated adenocarcinoma cells. Positron emission tomography (PET)-CT showed diffuse abnormal uptake in the bones and tail of the pancreas. Contrast whole-body CT showed a tumor measuring approximately 28 mm in diameter with poor enhancement in the tail of the pancreas. The patient’s final diagnosis was pancreatic cancer located in the tail of the pancreas with diffuse bone metastases and DIC. His DCBM was thus believed to originate from the pancreatic cancer. He succumbed to the disease approximately 2 months after admission to our hospital. We herein describe a case of pancreatic cancer located in the tail of the pancreas with diffuse bone metastases and DIC, which, in our case, was DCBM. Therefore, in cases of DCBM with an unknown primary tumor, pancreatic cancer should be considered during differential diagnosis.